Recent studies have shown that ATG4B promotes the proliferation and progression of various tumor cells, and enhances the drug resistance of HCC cells through inducing protective autophagy (Rothe et al., 2014; Zhang et al., 2017; Agrotis and Ketteler, 2019; Liu P. F. et al., 2019). Here, ATG4B is linked to neoplasm.